Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival
Cachexia is a metabolic syndrome leading to muscle and adipose tissue loss in majority of cancer patients. Here the authors show that, in a mouse model, BET inhibitor JQ1 counteracts muscle and adipose tissue wasting tempering cachexia and prolonging survival through a mechanism unrelated to tumour...
Enregistré dans:
Auteurs principaux: | Marco Segatto, Raffaella Fittipaldi, Fabrizio Pin, Roberta Sartori, Kyung Dae Ko, Hossein Zare, Claudio Fenizia, Gianpietro Zanchettin, Elisa Sefora Pierobon, Shinji Hatakeyama, Cosimo Sperti, Stefano Merigliano, Marco Sandri, Panagis Filippakopoulos, Paola Costelli, Vittorio Sartorelli, Giuseppina Caretti |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ef40f2fb5f1d4f3e935dd2d92c2e1436 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis
par: Thomas C. Roberts, et autres
Publié: (2017) -
BETs inhibition attenuates oxidative stress and preserves muscle integrity in Duchenne muscular dystrophy
par: Marco Segatto, et autres
Publié: (2020) -
Analysis of the papillomavirus E2 and bromodomain protein Brd4 interaction using bimolecular fluorescence complementation.
par: Christine M Helfer, et autres
Publié: (2013) -
Mitochondrial Dysfunction in Cancer Cachexia: Impact on Muscle Health and Regeneration
par: Marc Beltrà, et autres
Publié: (2021) -
A chemical toolbox for the study of bromodomains and epigenetic signaling
par: Qin Wu, et autres
Publié: (2019)